Rivaroxaban for the prevention of stroke and systemic embolism in people with atrial fibrillation

Technology appraisal guidance
Reference number: TA256
Published: 23 May 2012
Last updated: 02 July 2021

Evidence

Supporting evidence

Review decision
Review decision April 2013
Appendic A: review decision paper (PDF 195 KB)

Published:

15 April 2013